Immunodeficiency in Children
The continuous interaction of metazoan hosts and microbiological pathogens is a feature of natural competitive existence. Most of us resist commonplace infections at the cost of some symptoms but with success, although subclinical infections are also common. More virulent, sometimes epidemic infections have left their considerable toll in the history of mortality. The immunodeficient child resists effectively neither the commonplace nor the major infection and a clinical picture is built up of repeated or unresolved infections which may be bacterial, fungal or viral, together with failure to thrive, and a pattern of social and educational disability. In an increasing number of such cases it has become possible to apply appropriate laboratory investigations to assess the child's immunological resources and define specific kinds of immunodeficiency.
The protective immunological resources consist of: antigen-sensitive lymphoid tissue, in which T and B lymphocytes are differentiated to serve specific cell-mediated and humoural antibodymediated functions respectively; and nonspecific factors which include the components of complement, lactoferrin and other iron-carrying proteins, together with lyzozyme and interferon. Perhaps most important and phylogenetically older, however, are the various kinds of phagocytic cells.
The fetus develops recognizable lymphoid tissue, in the thymic area, later definable structurally as thymus, from the seventh to ninth weeks of gestation (Gilmor 1941) . Thymus-dependent lymphocytes may be enumerated by sheep red cell rosette formation by the eleventh week (Stites et al. 1972) . By the fourteenth week such cells appear to respond to phytohemagglutinin with blast cell transformation (Kay et al. 1970) . Lymph nodes, the major source of humoural antibody are not found until the second trimester but B cells bearing immunoglobulin markers can be found at the eleventh week (Hayward & Ezer 1974) . The T-cell system is ready for antigen sensitization soon after viability is achieved so that BCG vaccination can be used safely and Mantoux conversion observed in the preterm infant (Gaisford 1955) although in practice it is usually deferred. IgG and IgM are synthesized in small amounts in the uninfected fetus and in fetal tissues in vitro (Gitlin & Biasucci 1969) . From birth or soon after both secretory and serum forms of IgA immunoglobulin and serum IgE immunoglobulin become detectable. IgD is usually found in the serum a few weeks after birth.
Serum immunoglobulin deficiency affecting all classes of immunoglobulin (Bruton 1952) has been recognized longer than other forms of immunodeficiency. Recently the high incidence of transient IgA deficiency in children with respiratory infections, and its importance in the pathogenesis of asthma and atopy have been recognized (Taylor et al. 1973 ). The frequent occurrence of IgA deficiency and the wide variety of partial immunoglobulin deficiency states in which other systems or structures may also be abnormal has created a large number of clinical problems together with a large literature. Thus, for example, IgA deficiency is found in partial deletions of chromosome 18 or a ring chromosome abnormality (Claman et al. 1970 ).
Deficiency of cell-mediated immunity results
from T-cell deficiency. In its most severe form, the severe combined immunodeficiency syndrome (SCID), it is complicated by hypogammaglobulinemia. The combination is associated with failure to thrive, with diarrhoea, and with bacterial, fungal and viral infections. There is usually lymphopenia. T cells may be enumerated by their property of forming rosettes with sheep red cells and there is responsiveness to stimulation, assessed by their blast cell transformation with nonspecific mitogens now known as T lectins (phytohmmagglutinin, concanavalin and poke weed mitogen) and also to. specific antigens. In many such children lymphoid tissue is minimal and Hassal's corpuscles are absent from the thymus. A number of these patients have also been found to be deficient in adenosine deaminase (Pickering et al. 1974 (Hong et al. 1976 ). The time shortly before and after transplantation is one of great danger, because of the risks of infection, but it is doubtful whether total environmental sterilization is needed. The use of immunoglobulin by injection at this time has something to commend it, p'rovided it is recognized that it offers no prospect of permanent cure.
Currently there is interest in treating such patients with levamisole, theophylline and thymosin. The former drug, a veterinary antihelminthic agent has been found to increase lymphocyte reactivity to mitogens in vitro and to increase IgA levels in groups of patients in which levels are low (Pabst & Crawford 1975) . Preliminary reports suggest that it may be of value in preventing or reducing the severity of recurrent respiratory tract infections in children (Van Eigin et al. 1976) . Theophylline may have similar effects (Hayward & Graham 1976) but there is less so far reported about its action. These drugs appear to exert their effects in different ways, the former enhancing cyclic guanosine monophosphate (GMP) and the latter cyclic adnosine monophosphate (CAMP) levels (Haddla et al. 1975 ). In the case of levamisole a contact effect may not be required.
A number of conditions exist in which T-cell deficiency occurs to a varying degree, sometimes with partial preservation of antibody-dependent immunity to an extent greater than that found in SCID. Among these is the Nezelof syndrome (Nezelof et al. 1964) in which some immunoglobulin synthesis is preserved but often with abnormal electrophoretic mobility, indicating an oligoclonal distribution of molecular species. The Di George syndrome may be a somewhat easier problem to deal with in the immunological sense, for although there are associated anomalies of the heart and congenital hypothyroidism the immunological deficiency is limited to congenital absence of the thymus and fetal thymus grafting may achieve successful reconstitution (Di George 1968) .
Humoral thymus factors have attracted interest for many years, since Osoba & Miller (1964) showed that thymus tissue placed in diffusion chambers may restore T-cell function in neonatal mice rendered immunodeficient by thymectomy. A similar therapeutic approach has been tried in naturally immunodeficient children and some success reported (Frenkel et al. 1974 ). Thymus factors have been partially purified and their action may not be species specific (Bach & Carnand 1976) . Candidiasis poses many interesting problems in immunology and is a prominent and frequent feature of the Di George syndrome. In combined immunodeficiency and hypogammaglobulinemia, granulomatous cutaneous lesions may be found (Valdimarsson et al. 1973) and such cases have been successfully treated with dialyzable transfer factor prepared from donors who show positive but normal delayed hypersensitivity to candida (Valdimarsson et al. 1972) . In these instances specific delayed hypersensitivity previously absent has been restored by transfer factor which has to be given by parenteral injection at intervals determined by response and continued need.
The phytogenetically older functions of phagocytosis and intracellular killing remain central to resistance to infection. Recently, disorders of phagocytosis have been recognized. Granulopenia leads to serious infection when the polymorphonuclear leukocyte count is below 500 per mm3.
Among specific varieties are infantile genetic agranulocytosis (Lang & Cutting 1965) and severe familial neutropenia (Hitzig 1959 ). The former is often fatal in infancy; the latter tends to improve and neither is well understood. Cyclical neutropenia, as its name implies, is neutropenia recurring briefly at regular intervals, usually on a 21-day cycle, and may improve. Impaired intracellular killing occurs in chronic granulomatous disease and, perhaps, in Job's syndrome, and also in myeloperoxidase deficiency, glucose-6-phosphate dehydrogenase deficiency (Cooper et al. 1972 ) and pyruvate kinase deficiency (Burge et al. 1976 (Rosenfeld & Leddy 1974) . Recently, nearly 25 % of children with recurrent infections, varying from mild to severe, have been found to have a defect of opsonization detected in this way (Soothill & Harvey 1976) . Plasma infusion may correct this defect.
Future developments in pediatric immunology will probably include the better definition of deficiency states in terms of molecular biology, and improvements in therapeutics may derive both from this and in the development of new pharmaceutical approaches, if grafting procedures remain limited by very precise HLA matching conditions.
